Total Payments
$1,698
2024 Payments
$437.72
Companies
27
Transactions
63
Medicare Patients
105
Medicare Billing
$1,911
Payment Breakdown by Category
Food & Beverage$1,513 (89.1%)
Education$184.95 (10.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,513 | 61 | 89.1% |
| Education | $184.95 | 2 | 10.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $429.36 | 20 | $0 (2024) |
| Aspira Women's Health Inc | $272.73 | 5 | $0 (2023) |
| Astellas Pharma US Inc | $184.95 | 2 | $0 (2023) |
| Gilead Sciences, Inc. | $148.42 | 2 | $0 (2024) |
| Amgen Inc. | $138.69 | 2 | $0 (2024) |
| Novo Nordisk Inc | $44.67 | 3 | $0 (2024) |
| TherapeuticsMD, Inc. | $41.56 | 3 | $0 (2021) |
| Agile Therapeutics, Inc. | $39.84 | 3 | $0 (2021) |
| Bayer HealthCare Pharmaceuticals Inc. | $37.09 | 2 | $0 (2021) |
| Exact Sciences Corporation | $33.96 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $437.72 | 19 | Amgen Inc. ($138.69) |
| 2023 | $540.34 | 13 | Gilead Sciences, Inc. ($118.45) |
| 2022 | $305.99 | 7 | Aspira Women's Health Inc ($122.77) |
| 2021 | $413.80 | 24 | AbbVie Inc. ($140.55) |
All Payment Transactions
63 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Obesity | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.79 | General |
| Category: NEUROSCIENCE | ||||||
| 11/29/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.69 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.34 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $124.46 | General |
| Category: Bone Health | ||||||
| 08/20/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Hematology | ||||||
| 08/08/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: OUD | ||||||
| 08/06/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Respiratory | ||||||
| 08/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: NEUROSCIENCE | ||||||
| 07/23/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Cardiology | ||||||
| 07/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Oncology | ||||||
| 07/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.30 | General |
| Category: NEUROSCIENCE | ||||||
| 06/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Obesity | ||||||
| 05/14/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.97 | General |
| 03/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: PSYCHIATRY | ||||||
| 01/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: NEUROSCIENCE | ||||||
| 01/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $42.63 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2023 | Aspira Women's Health Inc | OVA1 (Device) | Food and Beverage | In-kind items and services | $59.20 | General |
| Category: OB/GYN | ||||||
| 10/17/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: PSYCHIATRY | ||||||
| 09/19/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Diabetes | ||||||
| 09/15/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Diabetes | ||||||
| 08/16/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 41 | 50 | $1,546 | $563.88 |
| 2022 | 3 | 64 | 91 | $3,971 | $1,348 |
Total Patients
105
Total Services
141
Medicare Billing
$1,911
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 14 | 14 | $1,330 | $484.68 | 36.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 27 | 36 | $216.00 | $79.20 | 36.7% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 24 | 25 | $2,375 | $865.50 | 36.4% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 12 | 24 | $1,344 | $389.28 | 29.0% |
| 81003 | Automated urinalysis test | Office | 2022 | 28 | 42 | $252.00 | $92.72 | 36.8% |
About Kaitlyn Breiten, WHNP
Kaitlyn Breiten, WHNP is a Women's Health healthcare provider based in Robbinsville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/24/2019. The National Provider Identifier (NPI) number assigned to this provider is 1770147977.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kaitlyn Breiten, WHNP has received a total of $1,698 in payments from pharmaceutical and medical device companies, with $437.72 received in 2024. These payments were reported across 63 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($1,513).
As a Medicare-enrolled provider, Breiten has provided services to 105 Medicare beneficiaries, totaling 141 services with total Medicare billing of $1,911. Data is available for 2 years (2022–2023), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Women's Health
- Other Specialties Women's Health
- Location Robbinsville, NC
- Active Since 04/24/2019
- Last Updated 08/01/2023
- Taxonomy Code 363LW0102X
- Entity Type Individual
- NPI Number 1770147977
Products in Payments
- OVA1 (Device) $272.73
- VRAYLAR (Drug) $267.38
- EVENITY (Biological) $124.46
- Epclusa (Drug) $118.45
- LO LOESTRIN FE (Drug) $116.43
- Twirla (Drug) $39.84
- CAPLYTA (Drug) $37.45
- Kyleena (Drug) $37.09
- Cologuard Collection Kit (Device) $33.96
- SLYND (Drug) $30.49
- ABILIFY MAINTENA (Drug) $29.40
- MOUNJARO (Drug) $29.07
- Wegovy (Drug) $28.43
- ANNOVERA (Drug) $27.02
- SUBLOCADE (Drug) $24.61
- ORILISSA (Drug) $24.12
- INJECTAFER (Drug) $23.39
- UBRELVY (Drug) $21.43
- AREXVY (Drug) $21.33
- NEXPLANON (Drug) $19.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.